Upgrade to SI Premium - Free Trial

Medtronic, Inc. (MDT) PT Raised to $138 at Truist Securities

May 28, 2021 3:55 AM
Truist Securities analyst Kaila Krum raised the price target on Medtronic, Inc. (NYSE: MDT) to $138.00 (from $132.00) while maintaining a Buy rating.

Categories

Analyst PT Change

Next Articles